18 20 Kansas Kansas EyeCon EyeCon May 11 & 12, 2018 The Venue 4800 W 135th St., Ste. 108 Leawood, KS 66209 Sponsored by the University of Kansas Department of Ophthalmology and the Lemoine Alumni Society Kansas EyeCon 2018 We wish to acknowledge and sincerely thank these organizations for exhibiting at this conference: Platinum Sponsors: Glaukos Corporation Halozyme Therapeutics IRIDEX Corporation Regeneron Pharmaceuticals, Inc. Saving Sight Silver Sponsors: Alcon Surgical Allergan Carl Zeiss Meditec, Inc. Leica Microsystems, Inc. Marco Novartis/Alcon Pharmaceuticals Bronze Sponsor: KU Audio‐Reader Network Kansas EyeCon 2018 May 11 & 12, 2018 Program Overview ‐ This conference is intended to provide ophthalmologists with an educational forum to learn about new developments in the profession and their application to patient care. Covering a cross‐section of all sub‐specialties, physicians can expect to walk away having heard evidence‐based presentations. Target Audience ‐ This program is designed to meet the needs of practicing ophthalmologists. Learning Objectives ‐ Upon completion of the educational activity, participants should be able to: Cornea and Orbital Session 1. Examine complication rates as well as visual outcomes of resident‐performed cataract surgery at a VA Medical Center; 2. Compare outcomes and complication rates between senior and non‐senior residents; 3. Recognize indications for MSICS/Extracapsular Cataract Surgery; 4. Identify the steps for performing MSICS; 5. Recognize conclusions from published results of DREAM Study; 6. Discuss the practical applications; 7. Compare DREAM to other recent publications on role of Omega 3 oils in ocular surface health; 8. Analyze patterns of oculofacial injury due to hoof‐kicks from horses; 9. Determine the severity, outcome, and management of patients who sustained oculofacial injuries as a result of being kicked by a horse; 10. Establish how oculoplastics training in residency affects resident’s perceived comfort level with common oculoplastics procedures; 11. Describe the pathophysiology of thyroid eye disease; 12. Discuss a case series of patients who underwent orbital decompression for thyroid orbitopathy and demonstrated radiographic expansion of extraocular muscles post‐operatively; 13. Demonstrate a successful insertion of a scleral fixated intraocular lens through a small corneal incision; 14. Discuss the clinical findings of cavernous hemangioma; 15. Recognize the surgical approaches for removal; 16. Examine the historical origins and basic principles of laser photodisruption and photocoagulation, contrast sensitivity and variable contrast acuity testing, scanning laser and aspheric contact lens ophthalmoscopy and radiant energy protective intraocular lenses. Glaucoma and Anterior Segment Session 17. Describe the anatomic and physiologic role of the lens in angle closure glaucoma; 18. Explain the benefits of lens extraction in treating angle closure glaucoma and compare with alternative treatments; 19. Discuss the fundamental limitations affecting management of glaucoma; 20. Familiarize with new developments in glaucoma; 21. Discuss anatomy and 360 degree treatment vs 180 degree treatment; 22. Analyze resident laser data to determine results and efficacy; 23. Identify different types of MIGS procedures; 24. Recognize when/if it is appropriate to utilize different types of MIGS procedures. Pediatric and Retina Session 25. Recognize the clinical presentation of ocular juvenile xanthogranuloma; 26. Describe management of ocular juvenile xanthogranuloma; 27. Analyze the differences in keratoconus diagnosis and treatment between adults and children; 28. Describe the current controversies in the field of corneal crosslinking; 29. Discuss therapeutic options for central serous chorioretinopathy; 30. Explain outcomes of patients undergoing treatment for central serous chorioretinopathy; 31. Explain the concept of the ophthalmic endoscope; 32. Recognize current role of ophthalmic endoscopy in vitreoretinal surgeries. Method of Participation Statements of credit will be awarded based on the participant's attendance and will be available upon completion of an online evaluation/claimed credit form available at akhinc.formstack.com/forms/kseyecon. Alternatively, a statement of credit will be awarded based on the participant’s attendance and submission of the activity evaluation form. A statement of credit will be available upon completion of an evaluation/claimed credit form that should be turned in at the end of the meeting. If you have questions about this CME activity, please contact AKH Inc. at [email protected]. This activity has been planned and implemented in accordance with the Essential Areas and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of AKH Inc., Advancing Knowledge in Healthcare and the University of Kansas, Department of Ophthalmology and The Lemoine Alumni Society. AKH Inc., Advancing Knowledge in Healthcare is accredited by the ACCME to provide continuing medical education for physicians. AKH Inc., Advancing Knowledge in Healthcare designates this live activity for a maximum of 7.0 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity. CME Credit Provided by AKH Inc., Advancing Knowledge in Healthcare Physicians FACULTY DISCLOSURES Name Relationship Commercial Interest Radwan Ajlan, MD N/A Nothing to Disclose Neeti Alapati, MD N/A Nothing to Disclose Denise Capps, MD N/A Nothing to Disclose Luke Dolezal, MD N/A Nothing to Disclose Speakers Bureau Aerie Pharmaceuticals Inc.; Allergan Inc.; Novartis Pharmaceuticals Corp. Consultant Aerie Pharmaceuticals Inc.; Allergan Inc.; Novartis Scott Fudemberg, MD Pharmaceuticals Corp. Michael Gilbert, MD N/A Nothing to Disclose Christina Donaghy Gillmor, MD N/A Nothing to Disclose Yong Kam, MD N/A Nothing to Disclose Joshua Jones, MD N/A Nothing to Disclose Katie Keck, MD N/A Nothing to Disclose Martin Mainster, MD N/A Nothing to Disclose Jonathan Manhard, MD N/A Nothing to Disclose Reid Mollman, MD N/A Nothing to Disclose Jason Sokol, MD N/A Nothing to Disclose Erin Stahl, MD N/A Nothing to Disclose John Sutphin, MD N/A Nothing to Disclose W. Abraham White, MD N/A Nothing to Disclose Thomas Whittaker, MD N/A Nothing to Disclose Annie Wishna, MD N/A Nothing to disclose PLANNER DISCLOSURES KUMC/KSEPS Staff and Planners N/A Nothing to Disclose AKH Staff and Planners N/A Nothing to Disclose Commercial Support There is no commercial support for this activity. Disclosures It is the policy of AKH Inc. to ensure independence, balance, objectivity, scientific rigor, and integrity in all of its continuing education activities. The author must disclose to the participants any significant relationships with commercial interests whose products or devices may be mentioned in the activity or with the commercial supporter of this continuing education activity. Identified conflicts of interest are resolved by AKH prior to accreditation of the activity and may include any of or combination of the following: attestation to non‐commercial content; notification of independent and certified CME/CE expectations; referral to National Author Initiative training; restriction of topic area or content; restriction to discussion of science only; amendment of content to eliminate discussion of device or technique; use of other author for discussion of recommendations; independent review against criteria ensuring evidence support recommendation; moderator review; and peer review. Disclosure of Unlabeled Use and Investigational Product This educational activity may include discussion of uses of agents that are investigational and/or unapproved by the FDA. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings. Disclaimer This course is designed solely to provide the healthcare professional with information to assist in his/her practice and professional development and is not to be considered a diagnostic tool to replace professional advice or treatment. The course serves as a general guide to the healthcare professional, and therefore, cannot be considered as giving legal, nursing, medical, or other professional advice in specific cases. AKH Inc. specifically disclaim responsibility for any adverse consequences resulting directly or indirectly from information in the course, for undetected error, or through participant's misunderstanding of the content. LEMOINE DISTINGUISHED ALUMNI LECTURERS LECTURER TITLE DATE Timothy W. Olsen, MD Rock Chalk Retina Talk: 100 year KU 5/9/2014 KU SOM MD ‘89 Luther L. Fry, MD Standard Cataract Surgery: Tips & Tricks 5/8/2015 KU SOM MD ‘67 Learned after 40,000+ Cases John D. Hunkeler, MD Continuous Education 4/8/2016 KU SOM MD ‘67 KU Eye Residency ‘73 William A. Godfrey, MD Quality of Life for Ophthalmology: 5/12/2017 KU SOM MD ’65 A Perspective KU Eye Residency ‘71 Martin A. Mainster, PhD, MD, A Physicist’s Adventures in RetinaLand 5/11/2018 FRCOphth, Luther & Ardis Fry Professor Emeritus Alumni Speakers Scott Fudemberg, MD Residency: 2007 Erin Stahl, MD Residency: 2009; Fellow: 2011 Thomas J. Whittaker, MD MD: 1990 AGENDA Kansas EyeCon May 11 – 12, 2018 The Venue Friday, May 11, 2018 12:00 p.m. Registration and lunch with exhibitors 1:00 p.m. Welcome: Neeti Alapati, MD Cornea and Orbital Session 1:05 p.m. Michael Gilbert, MD, Comparative Review of Complication Rates and Visual